Primary objective: To evaluate the safety and tolerability of cenobamate in pediatric subjects 2-17 years of age with partial-onset (focal) seizures.
Study Details
Internal Title:
YKP3089C040
PCH IRB Number:
IRB-21-258
Clinical Trials Government Identifier:
NCT05067634
Diagnoses & Treatments:
Focal seizures, Cenobamate, Partial-Onset Seizures
Study Type:
Clinical Trial
Eligibility:
2-<6 years old. Have a diagnosis of epilepsy with partial-onset (focal) seizures (POS) with or without secondarily generalized seizures. Stable doses of 1 to 3 approved antiepileptic drugs
Enrollment Status:
Open
Phase:
I